The aim of the study was to evaluate end effect of different doses of estradiol and BMI changes by the time of therapy and BMI changes before therapy. We found that most important is to increase body mass to have regular cycles and there is no difference from statistical point of view to use different doses of estradiol (constant v. step down protocol). We used different progestogenic agents: medroksyprogesteron and dydrogesteron.